“111引智计划”专家报告

题目：Cancer Epidemiological Study at CPF: Evidence from Real-World Clinical Data

主讲人：Dr. Jianguang Ji 

时间：2022年6月29日（星期三）下午16:00

地点：生科楼2018（也可通过zoom线上参加，会议ID：895 8567 3162）

邀请人：赵要风      62731142-2003

个人简介

EDUCATION

2005-2008 Ph. D, School of Medicine, University of Heidelberg, Germany

1997-2000 Master of Public Health, Chinese Academy of Preventive Medicine, China

1992-1997 MD, Zhangjiakou Medical College, China

CURRENT POSITION

2019 – Now Senior Lecturer, Center for Primary Health Care Research, Clinical Research Center, Lund University/Sweden

PREVIOUS POSITIONS

2009 – 2019 Senior Researcher, Center for Primary Health Care Research, Lund University

2006 – 2008 Assistant Researcher, Center for Family Medicine, Karolinska Institute

2004 – 2005 Assistant Researcher, Department of Bioscience, Karolinska Institute

CURRENT RESEARCH INTERESTS

His research has a strong focus on the influence of genetic and environmental factors on cancer incidence and mortality. He has used data from nationwide registers and national and regional surveys to shed new light on potential genetic and environmental factors associated with the development of various types of cancer. Results from his research studies can be found in highly ranked journals, such as The Lancet Oncology, J National Cancer Inst, Gastroenterology, and J Clin Oncol, et al.  

PUBLICATION

1. Zhang N, Sundquist J, Sundquist K, Zhang ZG, Ji J. Combined Use of Aspirin and Selective Serotonin Reuptake Inhibitors Is Associated With Lower Risk of Colorectal Cancer: A Nested Case-Control Study. Am J Gastroenterology, 2021. 116(6):1313-1321.

2. Zheng G, Sundquist J, Sundquist K, Ji J. Association of post-diagnostic use of cholera vaccine with survival outcome in breast cancer patients. Br J Cancer, 2021. 124(2):506-512.

3. Huang W, Sundquist J, Sundquist K, Ji J. Phosphodiesterase-5 inhibitors use and risk for mortality and metastases among male patients with colorectal cancer. Nature Communication 2020. 11(1):3191